NewAmsterdam Pharma N.V.
NAMS | NASDAQ
$23.44
+$0.86 (+3.81%)
Sep 22, 2026, 12:40 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Net Income | -203.82M | -241.6M | -176.94M | -22.63M | -41.79M | -7.07M |
Depreciation & Amortization | 220K | 113K | 49K | 9K | 5K | 1.23K |
Stock-Based Compensation | 59.43M | 33.62M | 24.57M | 4.12M | 1.24M | n/a |
Other Working Capital | 427K | -19.73M | -3.23M | 9.75M | -2.09M | -649.41K |
Other Non-Cash Items | 4.34M | 81.98M | 5.23M | 18.8M | 6.55M | 376.37K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -7.94M | -32.67M | 5.87M | 10.37M | 4.47M | -649.41K |
Operating Cash Flow | -147.78M | -158.56M | -141.22M | 10.67M | -29.51M | -7.34M |
Capital Expenditures | -246K | -672K | -24K | -221K | -24K | -15.99K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -296.73M | -62.18M | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 122.06M | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -174.92M | -62.85M | -24K | -221K | -24K | -15.99K |
Debt Repayment | n/a | n/a | n/a | 747K | n/a | 13.92M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | 14M | n/a | -5.79M | n/a | n/a |
Financial Cash Flow | 29.52M | 659.51M | 8.91M | 391.91M | 84.7M | 13.92M |
Net Cash Flow | -280.42M | 431.29M | -127.28M | 407.6M | 50.49M | 6.59M |
Free Cash Flow | -148.03M | -159.24M | -141.24M | 10.44M | -29.54M | -7.36M |
Adj. Free Cash Flow | -207.45M | -192.86M | -165.81M | 6.33M | -30.78M | -7.36M |
Maintenance CapEx | -246K | -450.12K | -24K | n/a | -5K | -1.23K |
Growth CapEx | n/a | -221.89K | n/a | -221K | -19K | -14.76K |
Owner Earnings | -148.03M | -159.01M | -141.24M | 10.67M | -29.52M | -7.34M |
Add to Watchlist
Select watchlists to add or remove NAMS